07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

evoked cholinergic signal amplitudes were significantly smaller (WT: 3.05±0.16 κM; β2 KO:<br />

1.78±0.64 κM). The decay rate (t50) of nicotine-evoked signals did not differ between the strains<br />

(WT: 14.47±2.42s; β2 KO: 14.67±0.97s). ABT-089 did not elicit cholinergic transients in β2 KO<br />

mice. In α7 KO mice, the amplitudes of nicotine and ABT-089 evoked cholinergic transients<br />

were identical to those recorded in WT mice. Nicotine-evoked cholinergic signals decayed faster<br />

in α7 KO mice (10.61±1.09s). These results are consistent with the hypothesis that the effects of<br />

ABT-089 are selectively mediated via β2-, but not α7-, containing nAChRs. Furthermore, α7containing<br />

nAChRs contribute to the regulation of cholinergic signal decay rate following<br />

nicotine administration. Ongoing experiments will determine if the amplitudes of glutamatergic<br />

signals in WT and KO mice predict the amplitudes of cholinergic signals. These experiments<br />

will test a neuropharmacological model suggesting that α4β2 nAChRs on glutamatergic<br />

(thalamic) afferents increase prefrontal glutamate release which in turn evokes cholinergic<br />

signals via NMDA and AMPA heteroreceptors located on cholinergic terminals. The continuing<br />

and slowly decaying release of acetylcholine evoked by nicotine is mediated in part via α7<br />

nAChRs and is predicted to be associated with less efficacious cognitive enhancement than the<br />

“sharp” signals evoked by α4β2-selective nAChR agonists.<br />

Disclosures: J. Ji, None; V. Parikh, None; M.W. Decker, Abbott Laboratories, A.<br />

Employment (full or part-time); Abbott Laboratories, E. Ownership Interest (stock, stock<br />

options, patent or other intellectual property); M. Sarter, Abbott Laboratories., B. Research<br />

Grant (principal investigator, collaborator or consultant and pending grants as well as grants<br />

already received); Abbott Laboratories., C. Other Research Support (receipt of drugs, supplies,<br />

equipment or other in-kind support); Abbott Laboratories., D. Speakers Bureau/Honoraria<br />

(speakers bureau, symposia, and expert witness).<br />

Poster<br />

290. Animal Cognition and Behavior: Learning and Memory: Pharmacology I<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 290.20/RR71<br />

Topic: F.02.j. Learning and memory: Pharmacology<br />

Support: CONACYT Scholarship 18533<br />

<strong>Title</strong>: Memory <strong>for</strong>mation and camp production: 5-ht1a and 5-ht7 receptors<br />

Authors: *G. P. GARCIA, A. MENESES;<br />

Dept Pharmacobiology, CINVESTAV, México, DF, Mexico

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!